Amgen/Wyeth Enbrel Supplies Replenished With Rhode Island Plant Approval

Amgen and Wyeth are in a position to resume full promotion of the rheumatoid arthritis agent Enbrel following FDA approval of a new manufacturing site in Rhode Island